Post-Mastectomy Pain Syndrome Clinical Evidence from a Cancer Pain Clinic

A retrospective analysis of 120 women with refractory post-mastectomy pain syndrome (PMPS) referred to a tertiary cancer pain clinic between January 2022 and September 2025. The dataset includes patient-reported measures like the Brief Pain Inventory and Pain Catastrophizing Scale, and classifies pain as nociceptive, neuropathic, or mixed. It was authored by Morsi Khashan and published under CC-BY-4.0 license.

Use Cases

• Classify post-mastectomy pain phenotypes (nociceptive, neuropathic, mixed) based on structured clinical assessment data.
• Identify factors associated with mixed pain presentations based on variables like multiplicity of pain sources and radiotherapy-attributed pain.
• Analyze correlations between pain intensity, interference, and catastrophizing scores using patient-reported outcome measures (BPI, PCS).

Strengths

• Includes data from 120 patients with detailed clinical assessments.
• Reports specific statistical findings, such as mixed pain accounting for 34.2% of cases and adjusted odds ratios for associated factors.
• Uses multivariable logistic regression and sensitivity analyses (Firth's penalized likelihood) for model stability.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is from a single tertiary clinic cohort, which may limit generalizability.

Provenance

Source

figshare, authored by Morsi Khashan.

Collection Method

Retrospective analysis of prospectively maintained data from a specialized cancer pain clinic.

Time Range

January 2022 to September 2025.

Freshness

Last updated 2026-04-15 04:36:38; freshness should be verified.

Geography

null